Targeting VPS72 Inhibits ACTL6A/MYC Axis Activity in Hepatocellular Carcinoma Progression

The mechanistic and therapeutically targeted role of VPS72, a novel copy number variations (CNVs) cis-driven gained gene identified by genome-wide CNV and transcriptome analyses in HCC, is not well understood.